Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applisonix was an Israeli medical aesthetics company that developed ultrasound-based hair removal devices for professional cosmetic use. Its lead product was the Selectif/Selectif Pro system, which used the company's proprietary IMPRESA ultrasound technology to deliver energy through the hair shaft to the follicle for long-term hair removal. The company was founded in the mid-2000s under the Ma'ayan Technology Ventures incubator and raised venture financing before pursuing a public listing in Israel. Applisonix later ceased operating as an independent company following a reverse-merger transaction with EndyMed, and the public entity continued under the EndyMed name. Historically, Applisonix sat at the intersection of healthcare equipment, medical aesthetics, and dermatology-focused device development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applisonix.